GLSI

Greenwich LifeSciences Stock Price

40.00
0.47 (1.19%)
Upgrade to Real-Time
Afterhours (Closed)
40.00

Low
3.262

52 Week Range

High
128.00

Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
$52.04
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
$67.09
Level 1 Starter
Monthly Subscription
for only
$15.87
VAT not included
Company Name Stock Ticker Symbol Market Type
Greenwich LifeSciences Inc GLSI NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.47 1.19% 40.00 20:00:00
Open Price Low Price High Price Close Price Prev Close
39.00 38.50 41.28 39.47 39.53
Bid Price Ask Price Spread News
37.39 40.00 2.61 - -
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
937 44,227 $ 39.71 $ 1,756,417 - 3.262 - 128.00
Last Trade Time Type Quantity Stock Price Currency
16:38:53 formt 100 $ 40.00 USD

Period:

Draw Mode:

Greenwich LifeSciences Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 515.83M 12.90M 4.05M $ - $ - -0.19 -189.40
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - - 2.70k 19.10%

more financials information »

Greenwich LifeSciences News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical GLSI Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week44.4145.2338.5040.9142,667-4.41-9.93%
1 Month44.5546.189938.5042.5154,479-4.55-10.21%
3 Months34.0248.9629.065940.26116,3405.9817.58%
6 Months37.7769.7719.520140.18392,3802.235.9%
1 Year5.00128.003.26244.51394,40135.00700.0%
3 Years5.00128.003.26244.51394,40135.00700.0%
5 Years5.00128.003.26244.51394,40135.00700.0%

Greenwich LifeSciences Description

Greenwich LifeSciences Inc is a biopharmaceutical company that is developing GP2, an immunotherapy designed to prevent the recurrence of breast cancer following surgery. GP2 is a 9 amino acid transmembrane peptide of the HER2/neu protein, a cell surface receptor protein that is expressed in a variety of common cancers, including expression in most breast cancers at low, intermediate, and high or overexpressor levels.


Your Recent History
NASDAQ
GLSI
Greenwich ..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.